Evidence map›Paper›PMID 41334436›Full record

ArticleFrontiers in endocrinology2025

Association of 25-hydroxyvitamin D with sex hormones and body composition in Chinese older adults.

Xinyu Miao, Cong Ma, Zhaoyan Gu, Shuangtong Yan, Yanping Gong, Guogang Xu

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xinyu Miao *Department of Endocrinology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Cong Ma *Health Management Institute, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Zhaoyan GuDepartment of Endocrinology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Shuangtong YanDepartment of Endocrinology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Yanping GongDepartment of Endocrinology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Guogang XuHealth Management Institute, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Evidence from several studies suggests that vitamin D deficiency is associated with reduced testosterone levels. However, evidence regarding the relationships between serum 25-hydroxyvitamin D [25-(OH)D] and sex hormones remains inconsistent. This study focuses on older adults, aiming to investigate the associations of 25-(OH)D with sex hormones and body composition. Methods: A cross-sectional study was conducted, enrolling 2472 older adults (1406 males; 1066 females) aged 60 years or older who underwent routine health examinations at the Chinese PLA General Hospital in 2018 and 2019. Anthropometric measurements, biochemical characteristics, sex hormones, body composition, and chronic comorbidities were compared after stratification by 25-(OH)D levels. Multiple linear regression and logistic regression analyses were performed to explore the relationships of 25-(OH)D status with sex hormones and body composition. Results: Among the older adults in this study, the proportion of those with insufficient/deficient vitamin D was 87.4% (1229/1406) in males and 91.8% (979/1066) in females. By 25-(OH)D stratification (from sufficiency to deficiency), males showed increasing trends in body mass index (BMI), waist circumference (WC), body fat percentage, muscle mass and basic metabolic rate, smoking rate, triglycerides (TG), parathyroid hormone (PTH), and prolactin (PRL), along with decreasing trends in albumin (Alb), serum calcium (Ca), high-density lipoprotein cholesterol (HDL-C), serum creatinine (Cr), aspartate aminotransferase (AST) and testosterone; females exhibited similar trends, with additional decreases in hemoglobin (Hb), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) (all P<0.05). In males, a 10 ng/ml decrease in 25-(OH)D was associated with a -0.95 (-1.46, -0.45) nmol/L change in T levels and a 26% higher risk of hypogonadism (defined as total testosterone <12 nmol/L), though these associations disappeared after adjusting for age and BMI. For every 10 ng/ml decrease in 25-(OH)D, body fat percentage, muscle mass, and basal metabolic rate increased in both older males and females. After adjusting for confounding factors, only body fat percentage increased by 0.30 (0.00, 0.59) % in older males. Conclusion: In elderly men, 25-(OH)D levels correlated positively with total testosterone, but this correlation may be BMI-dependent. Additionally, as 25-(OH)D levels decreased, body fat percentage increased in this group, suggesting a potential mediating role of increased BMI/adiposity in the vitamin D-testosterone relationship.

Indexed as

Body CompositionGonadal Steroid HormonesVitamin DVitamin D DeficiencyAgedAged, 80 and overBody Mass IndexChinaCross-Sectional StudiesEast Asian PeopleFemaleHumansMaleMiddle AgedTestosterone25-hydroxyvitamin DGonadal Steroid HormonesTestosteroneVitamin Dbody compositionbody mass indexolder adultssex hormonesvitamin D

Identifiers

PMID41334436
PMCPMC12665557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.